Katalyze AI

Summary active Updated Jul 6, 2026

This profile is AI-generated. If you spot an error, please help us fix it by sharing a URL to the correct information.

Location San Francisco, California / Toronto, Ontario
Founded 2024
Latest Stage Seed
Total Raised $10.5M

Investors

Gokul Rajaram seed (2026)
bonfire-ventures seed (2026)
marathon-management-partners 2026-07-06 (2026)

Founders

Reza Farahani CEO & Co-Founder
Shreyas Becker COO & Co-Founder
Hannes Bretschneider Chief AI Officer & Co-Founder
Matt Cruz Founding Engineer

About

Katalyze AI is an agentic-AI platform for pharmaceutical companies, letting scientists, engineers, and analysts in biopharma organizations build teams of AI agents that take on engineering, scientific, and manufacturing work 1. The company is dual-headquartered in San Francisco and Toronto and reports that its platform is already used by five of the world’s 20 largest pharmaceutical companies, including Sanofi 12. Katalyze was co-founded by Reza Farahani (CEO), Shreyas Becker (COO), Hannes Bretschneider (Chief AI Officer), and Matt Cruz (Founding Engineer), with backgrounds spanning AI, enterprise software, and life sciences 12.

Disclaimer: This is a lean profile built from initial round coverage and may be expanded as more information becomes available.

Funding History

Date Round Amount Lead Co-investors
2026-07-06 Seed $10.5M Bonfire Ventures Inovia Capital, Ripple Ventures, Alumni Ventures, Gokul Rajaram, Farzad Soleimani 123

What Investors Say

No independently sourced investor commentary beyond the announcement press release available at this time.

What Founders Say

CEO Reza Farahani framed the company’s ambition around pharmaceutical timelines: he cited the “eight to twelve years and more than two billion dollars” typical drug-development cost and said Katalyze aims to “cut that in half by 2030” through agentic tooling for operational and manufacturing processes 2.

Sources


  1. WebWire, “Katalyze AI Raises $10.5M to Build the Agentic Operating System for Pharmaceutical Companies,” July 6, 2026. Accessed July 2026. https://www.webwire.com/ViewPressRel.asp?aId=357045

  2. BetaKit, “Katalyze AI thinks the future of pharma operations is teams of AI agents,” July 6, 2026. Accessed July 2026. https://betakit.com/katalyze-ai-thinks-the-future-of-pharma-operations-is-teams-of-ai-agents/

  3. FinSMEs, “Katalyze AI Raises $10.5M in Seed Funding,” July 6, 2026. Accessed July 2026. https://www.finsmes.com/2026/07/katalyze-ai-raises-10-5m-in-seed-funding.html — Third independent primary source confirming $10.5M seed led by Bonfire Ventures with participation from Inovia Capital, Ripple Ventures, Alumni Ventures, and angel investors Gokul Rajaram and Farzad Soleimani.